{ "entity_id": "B-003288", "folder": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "name": "Gene Technology Ethics and Community Consultative Committee", "type": "Statutory Body", "jurisdiction": "Commonwealth", "portfolio": "Health, Disability and Ageing", "website": "https://www.ogtr.gov.au/committee/gteccc", "data_status": "partial", "completeness": { "has_strategy_brief": true, "has_strategy_structured": true, "has_vision": false, "has_kpi_targets": true, "has_kpi_results": true, "has_strategy_overview": true, "has_legislation_text": true, "has_legislation_structured": false, "has_global_initiatives_text": false, "has_global_initiatives_structured": false, "n_global_initiatives": 0, "has_ideas": true, "has_artifacts": true, "n_ideas": 12, "n_legislation": 0, "n_artifacts": 5, "n_kpi_targets": 2, "n_kpi_results": 2, "n_outcomes": 1, "verified_own_data": true }, "strategy_profile": { "status": "needs_review", "confidence": "medium", "summary": "The over-arching aim of the Guidance is to improve gene technology communication outcomes and to foster and support responsible communication about gene technology and the regulatory scheme.", "official_site_url": "https://www.ogtr.gov.au/committee/gteccc", "source_documents": [], "purpose": { "text": "The over-arching aim of the Guidance is to improve gene technology communication outcomes and to foster and support responsible communication about gene technology and the regulatory scheme.", "source_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "source_page": 1, "source_deep_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf#page=1" }, "vision": null, "strategic_priorities": [], "values": [ { "name": "Transparency", "description": "", "source_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "source_page": null }, { "name": "Integrity", "description": "", "source_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "source_page": null }, { "name": "Mutual engagement", "description": "", "source_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "source_page": null } ], "outcomes": [ { "name": "Outcome 1: Effective communication about gene technology", "description": "The aim is to improve gene technology communication outcomes and to foster and support responsible communication about gene technology and the regulatory scheme.", "activities": [ "Providing a reference point for OGTR and others who communicate about gene technology", "Formulating guiding principles for effective communication", "Developing case studies to assist with discussion" ], "source_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "source_page": 1, "source_deep_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf#page=1" } ], "performance_measures": [ { "code": "GTECCC01", "measure": "Number of guiding principles developed", "target": "6", "latest_result": "5", "status": "Partially achieved", "target_source_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "target_source_page": null, "result_source_url": "", "result_source_page": null }, { "code": "GTECCC02", "measure": "Number of case studies developed", "target": "6", "latest_result": "0", "status": "Not achieved", "target_source_url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "target_source_page": null, "result_source_url": "", "result_source_page": null } ], "document_alignment_terms": { "must_support": [ "The over-arching aim of the Guidance is to improve gene technology communication outcomes and to foster and support responsible communication about gene technology and the regulato" ], "watch_terms": [ "Number of guiding principles developed", "Number of case studies developed" ], "avoid_claiming_without_evidence": [] }, "review_note": "Structured strategy exists but is incomplete." }, "global_initiatives": null, "strategy": { "reporting_period": "2024-25", "corporate_plan_period": "2025-26", "vision": null, "vision_source_page": null, "purposes": "The over-arching aim of the Guidance is to improve gene technology communication outcomes and to foster and support responsible communication about gene technology and the regulatory scheme.", "purposes_source_page": 1, "how_we_deliver": null, "how_we_deliver_source_page": null, "government_priorities": [], "outcomes": [ { "name": "Outcome 1: Effective communication about gene technology", "description": "The aim is to improve gene technology communication outcomes and to foster and support responsible communication about gene technology and the regulatory scheme.", "key_activities": [ "Providing a reference point for OGTR and others who communicate about gene technology", "Formulating guiding principles for effective communication", "Developing case studies to assist with discussion" ], "source_page": 1 } ], "values": [ "Transparency", "Integrity", "Mutual engagement" ], "values_framework_name": "None", "kpi_targets_2025_26": [ { "code": "GTECCC01", "measure": "Number of guiding principles developed", "target": "6", "source_page": null }, { "code": "GTECCC02", "measure": "Number of case studies developed", "target": "6", "source_page": null } ], "kpi_results_2024_25": [ { "code": "GTECCC01", "measure": "Number of guiding principles developed", "result": "5", "status": "Partially achieved", "source_page": null }, { "code": "GTECCC02", "measure": "Number of case studies developed", "result": "0", "status": "Not achieved", "source_page": null } ], "_source_urls": { "annual_report_url": "", "corporate_plan_url": "" } }, "ideas": [ { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Regulation & Policy", "scale": "small", "title": "Regulatory burden scan for forms, guidance, and reporting", "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.", "quote": "The National Framework 2012:\nContext\n4.1 Regulatory scheme and the role of the Gene\nTechnology Regulator\nAll dealings with GMOs require authorisation under the Gene Technology Act 2000 (the GT Act).\n(See Appendix 1.) The objective of the GT Act is “to protect the health and safety of people and\nthe environment, by identifying risks posed by or as a result of gene technology, and by managing\nthose risks through regulating certain dealings with GMOs”.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/national_framework_of_ethical_principles.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/national_framework_of_ethical_principles.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Regulation & Policy", "scale": "large", "title": "Adaptive regulation program with live feedback loops", "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.", "quote": "The National Framework 2012:\nContext\n4.1 Regulatory scheme and the role of the Gene\nTechnology Regulator\nAll dealings with GMOs require authorisation under the Gene Technology Act 2000 (the GT Act).\n(See Appendix 1.) The objective of the GT Act is “to protect the health and safety of people and\nthe environment, by identifying risks posed by or as a result of gene technology, and by managing\nthose risks through regulating certain dealings with GMOs”.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/national_framework_of_ethical_principles.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/national_framework_of_ethical_principles.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Risk & Assurance", "scale": "small", "title": "Recommendation tracker for audits, reviews, and inquiries", "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.", "quote": "2.2.5 The obligation to “manage risk”\nOne further difference between the Gene Technology Act 2000 and mainstream\nenvironmental law is that the obligation to manage risk appears prominently in the\nGene Technology Act 2000 and in other risk assessment regimes that originate in the\nhealth and agriculture portfolios (therapeutic goods approval, chemicals regulation,\nquarantine, etc) whereas environmental law remains silent on ‘risk’.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in_australia_0.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Risk & Assurance", "scale": "large", "title": "Integrated assurance and lessons-learned system", "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.", "quote": "2.2.5 The obligation to “manage risk”\nOne further difference between the Gene Technology Act 2000 and mainstream\nenvironmental law is that the obligation to manage risk appears prominently in the\nGene Technology Act 2000 and in other risk assessment regimes that originate in the\nhealth and agriculture portfolios (therapeutic goods approval, chemicals regulation,\nquarantine, etc) whereas environmental law remains silent on ‘risk’.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in_australia_0.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Citizen Participation", "scale": "small", "title": "Consultation feedback summaries with response tracking", "idea": "Summarise consultation submissions by theme and publish what changed in response.", "quote": "[Page 33]\nAcronyms and abbreviations\nAPVMA Australian Pesticides and Veterinary Medicines Authority\nAEC Animal Ethics Committee\nFSANZ Food Standards Australia New Zealand\nGMAC Genetic Manipulation Advisory Committee (1987-2001)\nGMOs Genetically Modified Organisms\nGTCCC Gene Technology Community Consultative Committee (2001-2007)\nGTECCC Gene Technology Ethics and Community Consultative Committee\nGTEC Gene Technology Ethic Committee (2001-2007)\nGTTAC Gene Technology Technical Advisory Committee\nGTMC Gene Technology Ministerial Council\nGTSC Gene Technology Standing Committee\nHREC Human Research Ethics Committee\nIBCs Institutional Biosafety Committees\nIDC Inter-departmental Committee\nLGFGT Legislative & Governance Forum on Gene Technology (formerly Gene\nTechnology Ministerial Council, GTMC)\nNational Framework National Framework of Ethical Principles in Gene Technology", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "other-pdfs/national_framework_of_ethical_principles.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/national_framework_of_ethical_principles.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Citizen Participation", "scale": "large", "title": "Always-on policy participation platform", "idea": "Create a standing participation platform where citizens and stakeholders can propose, vote, and track ideas.", "quote": "[Page 33]\nAcronyms and abbreviations\nAPVMA Australian Pesticides and Veterinary Medicines Authority\nAEC Animal Ethics Committee\nFSANZ Food Standards Australia New Zealand\nGMAC Genetic Manipulation Advisory Committee (1987-2001)\nGMOs Genetically Modified Organisms\nGTCCC Gene Technology Community Consultative Committee (2001-2007)\nGTECCC Gene Technology Ethics and Community Consultative Committee\nGTEC Gene Technology Ethic Committee (2001-2007)\nGTTAC Gene Technology Technical Advisory Committee\nGTMC Gene Technology Ministerial Council\nGTSC Gene Technology Standing Committee\nHREC Human Research Ethics Committee\nIBCs Institutional Biosafety Committees\nIDC Inter-departmental Committee\nLGFGT Legislative & Governance Forum on Gene Technology (formerly Gene\nTechnology Ministerial Council, GTMC)\nNational Framework National Framework of Ethical Principles in Gene Technology", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "other-pdfs/national_framework_of_ethical_principles.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/national_framework_of_ethical_principles.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Case Processing", "scale": "small", "title": "Triage queue for stuck or ageing cases", "idea": "Use existing case data to flag ageing, duplicate, incomplete, or high-risk cases for earlier intervention.", "quote": "All requests\nogtr@health.gov.au\nEnquiries\n1800 181 030\nOGTR applications\nContact details for asking about, getting help with and submitting applications for licences, certification and accreditation.\nogtr.applications@health.gov.au\n1800 181 030\nMonitoring and Compliance Section\nContact the Monitoring and Compliance Section for guidance and advice about ongoing compliance requirements.\nogtr.m&c@health.gov.au\n1800 181 030\nLast updated:\n28 February 2022", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Applicants / case officers", "source": "pages/about.html (https://www.ogtr.gov.au/about-ogtr/contact-and-subscribe)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Case Processing", "scale": "large", "title": "End-to-end case processing redesign", "idea": "Redesign the case pathway around risk-based triage, reusable evidence, and automated eligibility checks.", "quote": "All requests\nogtr@health.gov.au\nEnquiries\n1800 181 030\nOGTR applications\nContact details for asking about, getting help with and submitting applications for licences, certification and accreditation.\nogtr.applications@health.gov.au\n1800 181 030\nMonitoring and Compliance Section\nContact the Monitoring and Compliance Section for guidance and advice about ongoing compliance requirements.\nogtr.m&c@health.gov.au\n1800 181 030\nLast updated:\n28 February 2022", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Applicants / case officers", "source": "pages/about.html (https://www.ogtr.gov.au/about-ogtr/contact-and-subscribe)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Staff Productivity", "scale": "small", "title": "Reusable briefing and summary assistant for internal documents", "idea": "Create controlled templates for summarising reports, submissions, minutes, and ministerial briefs.", "quote": "[Page 33]\nAcronyms and abbreviations\nAPVMA Australian Pesticides and Veterinary Medicines Authority\nAEC Animal Ethics Committee\nFSANZ Food Standards Australia New Zealand\nGMAC Genetic Manipulation Advisory Committee (1987-2001)\nGMOs Genetically Modified Organisms\nGTCCC Gene Technology Community Consultative Committee (2001-2007)\nGTECCC Gene Technology Ethics and Community Consultative Committee\nGTEC Gene Technology Ethic Committee (2001-2007)\nGTTAC Gene Technology Technical Advisory Committee\nGTMC Gene Technology Ministerial Council\nGTSC Gene Technology Standing Committee\nHREC Human Research Ethics Committee\nIBCs Institutional Biosafety Committees\nIDC Inter-departmental Committee\nLGFGT Legislative & Governance Forum on Gene Technology (formerly Gene\nTechnology Ministerial Council, GTMC)\nNational Framework National Framework of Ethical Principles in Gene Technology", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "other-pdfs/national_framework_of_ethical_principles.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/national_framework_of_ethical_principles.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Staff Productivity", "scale": "large", "title": "Department-wide knowledge and briefing platform", "idea": "Build a secure knowledge platform that lets staff search, summarise, and cite approved departmental material.", "quote": "[Page 33]\nAcronyms and abbreviations\nAPVMA Australian Pesticides and Veterinary Medicines Authority\nAEC Animal Ethics Committee\nFSANZ Food Standards Australia New Zealand\nGMAC Genetic Manipulation Advisory Committee (1987-2001)\nGMOs Genetically Modified Organisms\nGTCCC Gene Technology Community Consultative Committee (2001-2007)\nGTECCC Gene Technology Ethics and Community Consultative Committee\nGTEC Gene Technology Ethic Committee (2001-2007)\nGTTAC Gene Technology Technical Advisory Committee\nGTMC Gene Technology Ministerial Council\nGTSC Gene Technology Standing Committee\nHREC Human Research Ethics Committee\nIBCs Institutional Biosafety Committees\nIDC Inter-departmental Committee\nLGFGT Legislative & Governance Forum on Gene Technology (formerly Gene\nTechnology Ministerial Council, GTMC)\nNational Framework National Framework of Ethical Principles in Gene Technology", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "other-pdfs/national_framework_of_ethical_principles.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/national_framework_of_ethical_principles.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Data & Performance", "scale": "small", "title": "KPI evidence register with named owners", "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.", "quote": "[pages 16,17,18]\nent with the assessment of risks that\nare “…posed by or as a result of gene technology…” as required by the Gene Technology\nAct 2000 (s 3).\n(b) Harmfulness to other Organisms – target and non‐target\nDoes the Gene Technology Act 2000 oblige the protection of native invertebrates or\nother native organisms such as plants as part of the ecosystem or environment it seeks\nto protect?", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "other-pdfs/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in_australia_0.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "category": "Data & Performance", "scale": "large", "title": "Outcome dashboard linking budget, delivery, and public impact", "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.", "quote": "[pages 16,17,18]\nent with the assessment of risks that\nare “…posed by or as a result of gene technology…” as required by the Gene Technology\nAct 2000 (s 3).\n(b) Harmfulness to other Organisms – target and non‐target\nDoes the Gene Technology Act 2000 oblige the protection of native invertebrates or\nother native organisms such as plants as part of the ecosystem or environment it seeks\nto protect?", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "other-pdfs/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in.pdf (https://www.ogtr.gov.au/sites/default/files/files/2021-07/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in_australia_0.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] } ], "legislation_administered": [], "artifacts": [ { "category": "other-pdfs", "year": "2024", "url": "https://www.ogtr.gov.au/sites/default/files/2024-10/gene-technology-ethics-and-community-consultative-committee-gteccc_0.pdf", "file": "other-pdfs/gene-technology-ethics-and-community-consultative-committee-gteccc_0.pdf", "bytes": 534812, "link_text": "Download [Committee or Group] Gene Technology Ethics and Community Consultative Committee (GTECCC) (PDF) as PDF - 523 KB" }, { "category": "other-pdfs", "year": "2025", "url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "file": "other-pdfs/guidance_for_communicating_on_gene_technology_2025.pdf", "bytes": 309150, "link_text": "Download guidance_for_communicating_on_gene_technology_2025.pdf as PDF - 302 KB" }, { "category": "other-pdfs", "year": "2021", "url": "https://www.ogtr.gov.au/sites/default/files/files/2021-07/gteccc_advice_to_the_regulator_on_new_technologies_0.pdf", "file": "other-pdfs/gteccc_advice_to_the_regulator_on_new_technologies_0.pdf", "bytes": 144511, "link_text": "Download gteccc_advice_to_the_regulator_on_new_technologies.pdf as PDF - 142 KB" }, { "category": "other-pdfs", "year": "2021", "url": "https://www.ogtr.gov.au/sites/default/files/files/2021-07/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in_australia_0.pdf", "file": "other-pdfs/gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in.pdf", "bytes": 255164, "link_text": "Download gteccc_discussion_paper_environmental_ethics_as_it_relates_to_gene_technology_in_australia.pdf as PDF - 250 KB" }, { "category": "other-pdfs", "year": "2021", "url": "https://www.ogtr.gov.au/sites/default/files/files/2021-07/national_framework_of_ethical_principles.pdf", "file": "other-pdfs/national_framework_of_ethical_principles.pdf", "bytes": 848215, "link_text": "Download national_framework_of_ethical_principles.pdf as PDF - 829 KB" } ], "_meta": { "snapshot_built_at": "2026-05-14T02:12:56+00:00", "strategy_brief_meta": { "model": "nova-micro", "folder": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "annual_report": { "file": null, "url": "", "year": null }, "corporate_plan": { "file": "other-pdfs\\guidance_for_communicating_on_gene_technology_2025.txt", "url": "https://www.ogtr.gov.au/sites/default/files/2025-11/guidance_for_communicating_on_gene_technology_2025.pdf", "year": "guidance_for_communicating_on_gene_technology_2025" }, "usage": { "input_tokens": 7967, "output_tokens": 489, "total_tokens": 8456, "model": "nova-micro" }, "cost_usd": 0.000347305, "elapsed_seconds": 17.58, "generated_at": "2026-05-13T05:16:59+00:00" }, "ideas_manifest": { "entity_id": "B-003288", "entity_name": "Gene Technology Ethics and Community Consultative Committee", "folder_name": "Gene-Technology-Ethics-and-Community-Consultative-Committee", "generated_at": "2026-05-09T23:05:19.655331+00:00", "idea_count": 12, "markdown": "ideas/Gene-Technology-Ethics-and-Community-Consultative-Committee_ideas.md", "jsonl": "ideas/ideas.jsonl", "inputs": [ "Gene-Technology-Ethics-and-Community-Consultative-Committee_strategy-overview.md", "strategy-evidence.json", "global-intelligence/source-manifest.json" ] }, "global_intel_meta": null } }